Study finds slight increased risk of sudden vision loss with GLP-1 drugs
Glucagon-like peptide-1 (GLP-1) receptor agonists—widely prescribed for type 2 diabetes and obesity—may carry a small but clinically important safety signal, ...
Glucagon-like peptide-1 (GLP-1) receptor agonists—widely prescribed for type 2 diabetes and obesity—may carry a small but clinically important safety signal, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine